Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-20

Clinical Trial Update: A Study of GWP42006 in People With Focal Seizures - Part A [Phase 2]

View source ↗

Summary

Phase 2 trial update for GWP42006 in people with focal seizures (epilepsy) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GWP42006

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Epilepsy, Focal Seizures | Phase 2 | Status: COMPLETED